Key Takeaways
- Shares debuted at $20 in early June, dropped to $17.08, and recovered to $20.53 by Friday’s close
- Five of six initiating firms issued Buy ratings, creating an 83% bullish consensus
- Consensus price target stands at approximately $25, indicating over 20% potential upside
- Baird leads with a $30 target, pointing to “Cold War 2.0” defense spending trends
- AADX maintains over $1 billion in backlog with $522 million in trailing twelve-month revenue
Applied Aerospace & Defense (AADX) stock gained approximately 2% during Monday’s pre-market session following a coordinated coverage launch from six major Wall Street firms — with the overwhelming majority issuing bullish recommendations.
Applied Aerospace & Defense, Inc., AADX
Shares began trading at $20 on June 3 following the company’s initial public offering. The stock subsequently retreated to an intraday low of $17.08 before recovering to finish Friday’s session at $20.53. Monday’s analyst coverage provided the market with fresh fundamental perspectives on valuation.
Baird, Bank of America, Stifel, RBC Capital Markets, and Jefferies all assigned Buy-equivalent ratings to the defense manufacturer. Morgan Stanley stood as the only neutral voice with a Hold rating, though it still established a $23 price objective.
The consensus target among all six firms lands near $25 per share, representing more than 20% appreciation potential from current trading levels.
Baird topped the Street with a $30 price target, derived from a 25x multiple on its 2028 EBITDA forecast. In his research note, analyst Peter Arment positioned the company as a primary beneficiary of renewed investment in the “Arsenal of Freedom” — referencing the World War II production framework now being applied to contemporary defense expansion.
“The era of chronic underinvestment throughout the military-industrial base has ended,” Arment stated. He identifies a fundamental transformation moving away from traditional cost-plus agreements and away from procurement concentration among a limited number of prime contractors.
RBC Capital Markets launched coverage with an Outperform rating and $24 price target, building its valuation framework on a 19.5x multiple of projected 2028 adjusted EBITDA of $230 million. Stifel matched that $24 target, highlighting the company’s $1+ billion backlog as sufficient to drive approximately 14% annual organic revenue expansion through 2028.
Wolfe Research entered with an Outperform stance and $23 target, while Morgan Stanley’s $23 Hold rating reflected a more measured assessment of the post-IPO valuation framework.
Understanding AADX’s Business Operations
Applied Aerospace & Defense operates as a mid-tier provider to the aerospace and defense sectors. The company manufactures propellant storage tanks for orbital launch systems and produces critical components for SpaceX’s reusable Falcon 9 rocket platform.
Additional product lines include components for unmanned aerial vehicles and solid rocket motors integrated into missile systems. The company’s lineage extends beyond a century through the combination of Applied Aerospace Structures and PCX Aerosystems.
While the firm reports $522 million in trailing revenue and maintains a backlog that analysts view as a dependable growth catalyst, profitability remains elusive. This bottom-line challenge contributed to the stock’s initial post-IPO weakness.
Defense Budget Expansion Drives Analyst Confidence
Several initiating analysts highlighted increased U.S. defense appropriations as a multi-year favorable condition for specialized equipment manufacturers in AADX’s category.
Baird’s “Cold War 2.0” characterization resonated across other research reports, with firms viewing the current environment as a permanent — rather than temporary — escalation in defense hardware capital allocation.
Broader equity markets provided minimal support Monday, as the S&P 500 traded nearly unchanged and the Nasdaq composite dipped modestly lower. AADX’s pre-market advance stemmed exclusively from the analyst coverage wave.
With shares now trading above the $20 offering price and Baird’s $30 target suggesting approximately 43% upside potential, the 83% Buy rating ratio significantly exceeds the 55%–60% Buy consensus typical among S&P 500 constituents.
